CBIO
Crescent Biopharma, Inc.
14.50$
+3.9%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Crescent Biopharma, Inc. (CBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -72 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.3 | -8.2 | -30 | -30 | -43 | -52 | -39 | -57 | -46 | -35 | -31 | -72 | |
| 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.9 | 0.3 | 0.3 | 0.2 | 0.2 | 0.0 | 0.1 | |
| 1.6 | 2.3 | 3.0 | 3.8 | 4.6 | 6.2 | 6.9 | 6.1 | 3.9 | 3.6 | 4.8 | 13 | |
| 5.0 | 2.0 | -1.1 | -0.5 | 0.1 | -1.2 | 3.9 | -1.2 | -4.7 | -2.6 | 1.2 | -13 | |
| 0.2 | 0.3 | 0.7 | 0.3 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 73 | |
| -0.2 | -0.3 | -0.7 | -0.3 | -0.1 | -0.1 | -0.1 | 0.0 | -0.1 | 0.0 | 0.0 | -73 | |
| – | – | – | – | – | – | – | – | – | – | – | -0.2 | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0 | |
| 57 | 0.1 | 24 | 114 | 129 | 0.4 | 18 | 11 | 4.2 | 29 | 0.0 | 323 | |
| 53 | -8.4 | -6.8 | 84 | 86 | -52 | -21 | -47 | -42 | -6.1 | -31 | 179 | |
| -4.5 | -8.5 | -30 | -30 | -43 | -52 | -39 | -58 | -47 | -35 | -31 | -144 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.